162 related articles for article (PubMed ID: 27106834)
1. Drugs that Affect Cardiac Metabolism: Focus on Perhexiline.
Chong CR; Sallustio B; Horowitz JD
Cardiovasc Drugs Ther; 2016 Aug; 30(4):399-405. PubMed ID: 27106834
[TBL] [Abstract][Full Text] [Related]
2. Metabolic therapeutics in angina pectoris: history revisited with perhexiline.
Inglis S; Stewart S
Eur J Cardiovasc Nurs; 2006 Jun; 5(2):175-84. PubMed ID: 16469541
[TBL] [Abstract][Full Text] [Related]
3. Perhexiline maleate treatment for severe angina pectoris--correlations with pharmacokinetics.
Horowitz JD; Sia ST; Macdonald PS; Goble AJ; Louis WJ
Int J Cardiol; 1986 Nov; 13(2):219-29. PubMed ID: 3793279
[TBL] [Abstract][Full Text] [Related]
4. Emerging drugs for the treatment of angina pectoris.
Chong CR; Ong GJ; Horowitz JD
Expert Opin Emerg Drugs; 2016 Dec; 21(4):365-376. PubMed ID: 27686005
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of perhexiline maleate in refractory angina. A double-blind placebo-controlled clinical trial of a novel antianginal agent.
Cole PL; Beamer AD; McGowan N; Cantillon CO; Benfell K; Kelly RA; Hartley LH; Smith TW; Antman EM
Circulation; 1990 Apr; 81(4):1260-70. PubMed ID: 2180591
[TBL] [Abstract][Full Text] [Related]
6. Anti-anginal effects of partial fatty acid oxidation inhibitors.
Lam A; Lopaschuk GD
Curr Opin Pharmacol; 2007 Apr; 7(2):179-85. PubMed ID: 17307396
[TBL] [Abstract][Full Text] [Related]
7. Metabolic manipulation in ischaemic heart disease, a novel approach to treatment.
Lee L; Horowitz J; Frenneaux M
Eur Heart J; 2004 Apr; 25(8):634-41. PubMed ID: 15084367
[TBL] [Abstract][Full Text] [Related]
8. Systematic review of the efficacy and safety of perhexiline in the treatment of ischemic heart disease.
Killalea SM; Krum H
Am J Cardiovasc Drugs; 2001; 1(3):193-204. PubMed ID: 14728034
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic monitoring of the anti-anginal drug perhexiline maleate.
Cooper JD; Turnell DC; Pilcher J; Lockhart D
Ann Clin Biochem; 1985 Nov; 22 ( Pt 6)():614-7. PubMed ID: 4073793
[TBL] [Abstract][Full Text] [Related]
10. Effects of perhexiline and nitroglycerin on vascular, neutrophil and platelet function in patients with stable angina pectoris.
Liberts EA; Willoughby SR; Kennedy JA; Horowitz JD
Eur J Pharmacol; 2007 Mar; 560(1):49-55. PubMed ID: 17292880
[TBL] [Abstract][Full Text] [Related]
11. Perhexiline maleate in the treatment of angina pectoris. Five years of personal clinical experience.
Wallace DC
Med J Aust; 1978 Nov; 2(10):466, 493-5. PubMed ID: 33322
[TBL] [Abstract][Full Text] [Related]
12. Perhexiline.
Ashrafian H; Horowitz JD; Frenneaux MP
Cardiovasc Drug Rev; 2007; 25(1):76-97. PubMed ID: 17445089
[TBL] [Abstract][Full Text] [Related]
13. Beneficial clinical effects of perhexiline in patients with stable angina pectoris and acute coronary syndromes are associated with potentiation of platelet responsiveness to nitric oxide.
Willoughby SR; Stewart S; Chirkov YY; Kennedy JA; Holmes AS; Horowitz JD
Eur Heart J; 2002 Dec; 23(24):1946-54. PubMed ID: 12473257
[TBL] [Abstract][Full Text] [Related]
14. Multi-centre experience on the use of perhexiline in chronic heart failure and refractory angina: old drug, new hope.
Phan TT; Shivu GN; Choudhury A; Abozguia K; Davies C; Naidoo U; Ahmed I; Yousef Z; Horowitz J; Frenneaux M
Eur J Heart Fail; 2009 Sep; 11(9):881-6. PubMed ID: 19656806
[TBL] [Abstract][Full Text] [Related]
15. Perhexiline and hypertrophic cardiomyopathy: a new horizon for metabolic modulation.
Horowitz JD; Chirkov YY
Circulation; 2010 Oct; 122(16):1547-9. PubMed ID: 20921436
[No Abstract] [Full Text] [Related]
16. Pharmacokinetics of perhexiline maleate in anginal patients with and without peripheral neuropathy.
Singlas E; Goujet MA; Simon P
Eur J Clin Pharmacol; 1978 Nov; 14(3):195-201. PubMed ID: 729614
[TBL] [Abstract][Full Text] [Related]
17. Antianginal efficacy of perhexiline maleate in patients refractory to beta-adrenoreceptor blockade.
White HD; Lowe JB
Int J Cardiol; 1983 May; 3(2):145-55. PubMed ID: 6134684
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of angina pectoris with perhexiline maleate. Results and secondary effects].
Rodríguez Lambert JL; Simarro E; Moris C; Sieres M; Cortina A; Martínez C; Rodrigo L; Prado LS
Rev Esp Cardiol; 1984; 37(6):431-3. PubMed ID: 6522775
[No Abstract] [Full Text] [Related]
19. Soft drug derivatives related to perhexiline. Part II: In vivo studies.
Decker N; Grima M; Velly J; Marciniak G; Leclerc G; Schwartz J
Arzneimittelforschung; 1988 Aug; 38(8):1110-4. PubMed ID: 3196404
[TBL] [Abstract][Full Text] [Related]
20. Improvement in cardiac energetics by perhexiline in heart failure due to dilated cardiomyopathy.
Beadle RM; Williams LK; Kuehl M; Bowater S; Abozguia K; Leyva F; Yousef Z; Wagenmakers AJ; Thies F; Horowitz J; Frenneaux MP
JACC Heart Fail; 2015 Mar; 3(3):202-11. PubMed ID: 25650370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
